DPP4 and Alzheimer disease: This section of the review enumerates the possible therapeutic mechanisms for AD of metformin, GLP-1 receptor agonists, DPP4 inhibitors, insulin, and SGLT2 inhibitors, all of which are widely applied to patients with diabetes according to official Clinical Guidelines.